Vychodoslovensky ustav srdcovych a cievnych chorob a.s.;Univerzita Karlova;Ustav molekularni genetiky AV CR, v.v.i.
发明人:
申请号：
EP18209444.1
公开号：
EP3660046A1
申请日:
2018.11.30
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
The present invention relates to a combination of at least one IL-6 inhibitor, at least one VEGF-A inhibitor, and at least one MFGE-8 inhibitor. The invention further relates to a pharmaceutical preparation containing this combination of inhibitors, and to the use thereof as a medicament.
